ArticleBritish journal of clinical pharmacology2022

Joint modelling and simulation of M-protein dynamics and progression-free survival for alternative isatuximab dosing with pomalidomide/dexamethasone.

Hoai-Thu Thai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.